Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Depreciation and Depletion (2016 - 2025)

Fortress Biotech has reported Depreciation and Depletion over the past 13 years, most recently at $89000.0 for Q4 2025.

  • Quarterly results put Depreciation and Depletion at $89000.0 for Q4 2025, down 36.43% from a year ago — trailing twelve months through Dec 2025 was $415000.0 (down 59.19% YoY), and the annual figure for FY2025 was $400000.0, down 61.54%.
  • Depreciation and Depletion for Q4 2025 was $89000.0 at Fortress Biotech, down from $100000.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for FBIO hit a ceiling of $814000.0 in Q4 2022 and a floor of $89000.0 in Q4 2025.
  • Median Depreciation and Depletion over the past 5 years was $500000.0 (2021), compared with a mean of $479850.0.
  • Biggest five-year swings in Depreciation and Depletion: soared 33.33% in 2022 and later crashed 75.0% in 2024.
  • Fortress Biotech's Depreciation and Depletion stood at $732000.0 in 2021, then increased by 11.2% to $814000.0 in 2022, then crashed by 53.69% to $377000.0 in 2023, then plummeted by 62.86% to $140000.0 in 2024, then crashed by 36.43% to $89000.0 in 2025.
  • The last three reported values for Depreciation and Depletion were $89000.0 (Q4 2025), $100000.0 (Q3 2025), and $100000.0 (Q2 2025) per Business Quant data.